Fast-acting treatment for postpartum depression, if approved, could help hundreds of thousands of new mothers
March 15, 2019 at 13:30 PM EDT
A new treatment for postpartum depression, called brexanolone, is expected to be approved by the Food and Drug Administration this month.
